SAINT ANTOINE – Twelve hospitals in the San Antonio area will receive 63 cases of the antiviral drug Remdesivir to help COVID-19 patients recover.
This comes after an increase in coronavirus cases in recent weeks in the San Antonio area and in the state of Texas.
Governor Greg Abbott issued a press release on Saturday distributing the drug. The drug will also be distributed at the Fort Duncan Regional Medical Center at Eagle Pass, officials said.
These cases have been provided to DSHS through the United States Department of Health and Human Services and will constitute the sixth round of federal distribution.
According to 448 cases, authorities said it was the largest distribution of the drug to date and that it was enough to treat approximately 1,792 patients, according to a press release. This brings the state total to 1,425 cases distributed since May 12.
Of the 63 cases distributed, 59 will be in Bexar county. Three will be distributed in Comal County and one in Guadalupe.
“As Texas faces an increase in COVID-19 cases and hospitalizations, we remain committed to providing health care professionals with the resources they need to respond to this surge and support patients with COVID- 19, “said Abbott. “The State of Texas is grateful to the United States Department of Health and Human Services for its continued assistance in equipping Texas hospitals with Remdesivir. As we continue to fight the virus, Texas remains committed to keeping our communities healthy and safe. “
RELATED: San Antonio Hospitals Use Remdesivir For COVID-19 Treatment
Remdesivir has shown promise in early trials to accelerate recovery time in hospitalized COVID-19 patients, according to the press release.
Children’s hospitals are eligible for this round due to the powder formulation of the drug.
The medical staff at each hospital will determine how the medication will be used, in accordance with the Food and Drug Administration’s emergency use authorization. Officials said the drug will be given to adults and children hospitalized for serious illness, such as those in intensive care.
According to officials, preliminary results from a clinical trial showed that the average recovery time in patients who received Remdesivir was 11 days instead of 15 days with a placebo. The supply is part of a donation from the drug manufacturer Gilead.
RELATED: San Antonio Man Says Antiviral Remdesivir Helped Recover From COVID-19
Copyright 2020 by KSAT – All rights reserved.